Tag Archives: Raclopride

Therapeutic window for striatal dopamine D2/3 receptor occupancy in older patients with schizophrenia: a pilot PET study

Uchida H, Suzuki T, Graff-Guerrero A, Mulsant BH, Pollock BG, Arenovich T, Rajji TK, Mamo DC. Therapeutic window for striatal dopamine D2/3 receptor occupancy in older patients with schizophrenia: a pilot PET study. Am J Geriatr Psychiatry. October 2012. Publication Date October 2012 How Analyze was Used “An ROI analysis was completed by one of…

Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study

Egerton A, Shotbolt JP, Stokes PRA, Hirani E, Ahmad R, Lappin JM, Reeves SJ, Mehta MA, Howes OD, Grasby PM. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. Neuroimage. March 2010;50(1):260-266. Full Text – Open Access Publication Date March 2010 How Analyze was Used…

Can recreational doses of THC produce significant dopamine release in the human striatum?

Stokes PRA, Mehta MA, Curran HV, Breen G, Grasby PM. Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage. October 2009;48(1):186-190. Publication Date October 2009 How Analyze was Used “The deformed striatal atlas was used to sample counts from the add image using Analyze 8.0 software (www.analyzedirect.com).” Keywords Adult Analysis…

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation

Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am J Psychiatry. July 1998;155(7):921-928. Full Text – Open Access Publication Date July 1998 How Analyze was Used “The pertinent aspects are the following: striatal and cerebellar regions of…

Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

Brooks DJ, Ibanez V, Sawle GV, Playford ED, Quinn N, Mathias CJ, Lees AJ, Marsden CD, Bannister R, Frackowiak RSJ. Striatal D2 receptor status in patients with Parkinson’s disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol. February 1992;31(2):184-192. Publication Date February 1992 How Analyze was Used “Data…